scispace - formally typeset
M

Marie-France Champy

Researcher at University of Strasbourg

Publications -  44
Citations -  4334

Marie-France Champy is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Candidate gene & Gene. The author has an hindex of 23, co-authored 39 publications receiving 3832 citations. Previous affiliations of Marie-France Champy include Centre national de la recherche scientifique & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Variations in DNA elucidate molecular networks that cause disease

TL;DR: Application of this method to liver and adipose gene expression data generated from a segregating mouse population results in the identification of a macrophage-enriched network supported as having a causal relationship with disease traits associated with metabolic syndrome.
Journal ArticleDOI

SRC-1 and TIF2 Control Energy Balance between White and Brown Adipose Tissues

TL;DR: Results reveal that the relative level of TIF2/SRC-1 can modulate energy metabolism, which may contribute to weight gain on a high-fat diet.
Journal ArticleDOI

A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains

TL;DR: Comparison of C57BL/6J and C57bl/6N demonstrates a range of phenotypic differences that have the potential to impact upon penetrance and expressivity of mutational effects in these strains.
Journal ArticleDOI

Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62.

TL;DR: It is proposed that p62 normally antagonizes basal ERK activity and adipocyte differentiation and that its loss leads to the hyperactivation of ERK that favors adipogenesis and obesity.
Journal ArticleDOI

A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity

TL;DR: F-L-Leu improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice, yet it has a lower adipogenic activity, suggesting that it is a selective PPARgamma modulator that activates some (insulin sensitization), but not all (adipogenesis), PPARGamma-signaling pathways.